gettyKey FactsOxford University has begun searching for participants in the early-stage trial, the Financial Times reported Thursday, which will take around four months to complete and could begin as early as next week. All participants will receive one dose of the vaccine, with half set to receive a booster dose at a later point in time. The early-stage trial will enroll adults aged 18 to 40 from the Oxford area, and researchers will conduct four months of follow-up, according to a release posted Thursday. This includes booster shots to provide protection against variants and new, sometimes needleless, ways of administering vaccines. Volunteers will be tracked for four months to see make sure it's safe as part of the initial trial.
the ages of conquest has set an example of good epidemics.
( z0 set :ARG0 ( z1 age :mod ( z2 conquer ) ) :ARG1 ( z3 example :mod ( z4 epidemic :ARG1-of ( z5 good ) ) ) )
(z0 / set-02
    :ARG0 (z1 / age
              :mod (z2 / conquer-01))
    :ARG1 (z3 / example
              :mod (z4 / epidemic
                       :ARG1-of (z5 / good-02))))
the ages of conquest has set an example of good epidemics .
z1 :mod z2
z0 :ARG0 z1
z0 :ARG1 z3
z4 :ARG1-of z5
z3 :mod z4